Parabilis Medicines, Inc. Retained Earnings
Parabilis Medicines, Inc. (PBLS) had Retained Earnings of -$639.28 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$639.28M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$541.50M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$639.28M 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$541.50M 10-Q · filed 2026-08-13 |